Steven H Bernstein

Title: Innovations by Steven H Bernstein

Introduction

Steven H Bernstein is an accomplished inventor based in Lawrenceville, NJ (US). He holds two patents that contribute significantly to the field of cancer treatment. His work focuses on modified orthopoxvirus vectors and innovative methods for treating cancer.

Latest Patents

One of his latest patents involves modified orthopoxvirus vectors. This disclosure relates to these vectors and methods for their use in treating various cancers. The modified orthopoxvirus vectors exhibit beneficial therapeutic activities, including enhanced oncolytic activity, improved spread of infection, immune evasion, tumor persistence, and the capacity for incorporating exogenous DNA sequences. Additionally, these viruses are suitable for large-scale manufacturing protocols. Another patent focuses on methods of treating cancer using a combination of a monoclonal antibody and a specific compound, (R)-N-(4-chlorophenyl)-2-(cis-4-(6-fluoroquinolin-4-yl)cyclohexyl)propanamide, or a salt thereof.

Career Highlights

Throughout his career, Steven has worked with notable organizations such as the Ottawa Hospital Research Institute and Turnstone Biologics Corporation. His contributions to these institutions have been instrumental in advancing cancer research and treatment methodologies.

Collaborations

Steven has collaborated with esteemed colleagues, including John Cameron Bell and Fabrice Le Boeuf. These partnerships have fostered innovation and progress in their shared field of research.

Conclusion

Steven H Bernstein's work exemplifies the impact of innovative thinking in the medical field, particularly in cancer treatment. His patents and collaborations highlight his commitment to advancing therapeutic options for patients.